AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Here's Why We Have Concerns About the Cash Burn Situation at Neurotech International (ASX:NTI)
March 06, 2025 05:37 PM AEDT| By Team Kalkine MediaHighlights,Understanding cash burn is crucial for Neurotech International Limited's (ASX:NTI) stability.,The company faces a short cash runway, necessitating financial adjustments.,Potential shareholder dilution may occur if cash reserves need bolste...
Nova Eye Medical Limited's (ASX:EYE) 30% Stock Decline Could Present an Opportunity, but Careful Analysis Is Needed
March 06, 2025 05:34 PM AEDT| By Team Kalkine MediaHighlights,Recent share price decline sparks questions among shareholders.,Nova Eye Medical boasts strong revenue growth despite P/S ratio concerns.,Industry outlook exceeds forecasted growth, yet market sentiment remains wary.,Shareholders of Nova E...
Opthea's (ASX:OPT) First Half 2025 Financial Overview
March 06, 2025 05:33 PM AEDT| By Team Kalkine MediaHighlights,Opthea reports increased net loss for H1 2025,Significant revenue growth predicted over the next three years,Stock shows short-term decline of 18%,Opthea Ltd. (ASX:OPT) has disclosed its financial results for the first half of 2025. The co...
The largest shareholders in Paragon Care Limited (ASX:PGC), the insiders, might be disheartened by the recent 10% decline in stock value.
March 06, 2025 05:33 PM AEDT| By Team Kalkine MediaHighlights,Insiders hold significant control over Paragon Care Limited (PGC) with 69% ownership.,The top two shareholders account for 57% of the company's shares.,Institutional and general public ownerships also play key roles in the company's dynami...
Fisher & Paykel Healthcare (ASX:FPH) Expands Growth Plans with Major Infrastructure Investment
March 06, 2025 02:03 PM AEDT| By Team Kalkine MediaHighlights,Fisher & Paykel Healthcare (FPH) invests NZ$250 million in a new facility.,The expansion aims to support research, manufacturing, and distribution.,A long-term growth strategy includes a second New Zealand campus.,Fisher & Paykel Healthcar...
Mesoblast (ASX:MSB) Sees Market Dip Following ASX 200 Inclusion
March 06, 2025 01:38 PM AEDT| By Team Kalkine MediaHighlights,Mesoblast (MSB) slips over 5% despite ASX 200 inclusion,Stock experiences volatility after a massive 12-month surge,Company,maintains,strong long-term momentum in biotech space,Shares of Mesoblast (ASX:MSB) saw a decline of over 5% during...
Fisher & Paykel Healthcare (ASX:FPH) Expands Auckland Campus with NZ$250M Construction Project
March 06, 2025 12:27 PM AEDT| By Team Kalkine MediaHighlights,Fisher & Paykel Healthcare (FPH),initiates,a NZ$250M expansion at its East,Tāmaki,campus.,The new facility will house research, manufacturing, and distribution operations.,Completion expected in 2027 to support future product innovation.,F...
Healthcare Stocks See Renewed Optimism After Market Downturn
March 06, 2025 12:23 PM AEDT| By Team Kalkine MediaHighlights,Integral Diagnostics (IDX),and,Cochlear (,ASX:COH,),receive an improved outlook following recent market declines.,Integral Diagnostics (IDX),expected to,benefit,from regulatory changes and new contracts.,ResMed (,ASX:RMD,),shows strong ear...
Enlitic Partners with GE HealthCare for US Rollout of AI-Driven Genesis Imaging Solutions
March 06, 2025 01:50 AM AEDT| By Team Kalkine MediaHighlights,Enlitic (ENL) collaborates with GE HealthCare to enhance cloud-enabled medical imaging.,The Genesis portfolio introduces AI-powered tools for efficient imaging data management.,Amazon Web Services (AWS) supports the cloud deployment of Gen...
Clarity Pharmaceuticals Expands Cancer Research with New Copper-64 Isotope Supply Agreement
March 06, 2025 01:44 AM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (CU6) secures copper-64 supply for prostate cancer trials,Fast-track designation by the FDA accelerates research progress,Partnership strengthens local research and patient care initiatives,Clarity Pharmaceuticals (...
Recce Pharmaceuticals (ASX:RCE) Faces Continued Market Pressure Amid Revenue Growth
March 06, 2025 12:53 AM AEDT| By Team Kalkine MediaHighlights,Recce Pharmaceuticals (ASX:RCE) sees a 12% decline this week, adding to its three-year loss of 58%.,Despite a 49% annual revenue growth rate, market sentiment remains cautious.,Investors weigh long-term potential against near-term stock pr...
Neuren Pharmaceuticals’ (ASX:NEU) Long-Term Growth Shines Despite Recent Market Pullback
March 05, 2025 11:04 PM AEDT| By Team Kalkine MediaHighlights,Long-term surge: Neuren Pharmaceuticals' (NEU) stock has soared 597% over the past five years.,Recent turbulence: A 15% decline in the past month and a 37% drop over the last year.,Profitability milestone: Transition from losses to profita...
Ramsay Health Care (ASX:RHC): Unpacking the Earnings Dip and What Lies Ahead
March 05, 2025 10:39 PM AEDT| By Team Kalkine MediaHighlights,Unusual items impacted Ramsay Health Care’s (ASX:RHC) recent earnings.,One-time expenses suggest potential for stronger financials moving forward.,Future performance hinges on key factors beyond the latest results.,Ramsay Health Care (ASX:...
Oceania Healthcare (ASX:OCA) Strengthens Financial Position and Optimizes Operations for Growth
March 05, 2025 12:52 PM AEDT| By Team Kalkine MediaHighlights,Successful Debt Refinance:,Strong lender demand led to,optimal,pricing, extended tenor, and unchanged covenants.,Sales Growth and Expansion:,New sales,volumes up 29%, with ongoing developments enhancing occupancy.,Strategic Business,Optimi...
Clarity Pharmaceuticals Rises 7% Amid Promising Trial Results and New Supply Agreement
March 05, 2025 11:06 AM AEDT| By Team Kalkine MediaHighlights,Trial Progression:,Clarity Pharmaceuticals completed the Dose Escalation Phase of its SECuRE trial, with approval to advance to Phase II.,Safety and Efficacy Success:,The Safety Review Committee recommended progressing the trial based on p...
LTR Pharma Discovers Accelerated Route to U.S. Erectile Dysfunction Market
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,LTR Pharma introduces Roxus, aiming for early US market entry before FDA approval.,Healthcare stocks see minimal impact from Australia's recent federal budget.,Prescient Therapeutics launches a phase 2a trial for a novel blood cancer treatm...
Health Update: Clarity, Telix's Smaller Counterpart, Progresses to Next Stage of Prostate Cancer Treatment Trial
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals reports progress in prostate cancer therapy with a high response rate.,Race Oncology launches a clinical trial exploring the cardio-protective benefits of bisantrene.,Immuron expands its IBS treatment offerings acro...
Compumedics Receives FDA Approval for Another In-Home Sleep Testing Device
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Compumedics Limited (ASX:CMP) receives FDA clearance for its Falcon home sleep testing solution.,Falcon enhances Compumedics' Somfit technology, supporting its expansion in the US sleep diagnostics market.,Strong sales momentum in the US a...
Race secures significant contract to progress trial of cardioprotective anticancer therapy
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Race Oncology collaborates with George Clinical for the clinical development of RC220 bisantrene.,The trial is designed to assess RC220’s safety when combined with doxorubicin in advanced solid tumors.,Work order approval is set at approxi...
Biocurious: Given Recce's proximity, it was the ideal location to initiate a trial related to diabetes.
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Strategic Expansion:,Recce Pharmaceuticals is advancing its synthetic antibiotic R327 into a phase III trial in Indonesia, addressing the widespread issue of diabetic foot infections while leveraging the country's growing healthcare secto...
Advertise your brand on Kalkine Media